7Chen J, Liu Y, Liu W. A rneta-analysis of the biomarkers associ- ated with coronary artery lesions secondary to Kawasaki disease in Chinese children. J Huazhong Univ Sci Technolog Med Sci, 2011,31 (5) :705.
3Newburger JW, Takahashi M, Gerber MA, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from committee on rheumatic fever, endocarditis, and Kawasaki disease, council on cardiovascular disease in the young, American Heart Association. Circulation, 2004, 110: 2747-2771.
4KY, Hong JH, Han JW, et al. Features of Kawasaki disease at the extremes of age. J Paediatr Child Health, 2006, 42 : 423- 427.
5Chang FY, Hwang B, Chen SJ, et al. Characteristics of Kawasaki disease in infants younger than six months of age. Pediatr Infect Dis J, 2006, 25 : 241-244.
6Bums JC, Wiggins JW Jr, Toews WH, et al. Clinical spectrum of Kawasaki disease in infants younger than 6 months of age. J Pediatr, 1986, 109:759-763.
7Biezeveld MH, Geissler J, Weverling GL, et al. Polymorphisms in the mannose-binding lectin gene as determinants of age-defined risk of coronary artery lesions in Kawasaki disease. Arthritis Rheum, 2006, 54:369-376.
8Egami K, Muta H, Ishii M, et al. Prediction of resistance to intravenous immunoglobulin treatment in patients with Kawasaki disease. J Pediatr, 2006, 149: 237-240.
9胡亚美,江载芳.渚福棠实用儿科学[M].第7版.北京:人民卫生出版社,2002:698-705.
10Chuang CH, Hsiao MH, Chiu CH, et al. Kawasaki diseasein infants three months of age or younger [J]. J Microbiol Immunol infect, 2006, 39 (5): 387-391.
